ImmuCell Corporation

ImmuCell Corporation - Current Ratioverified

ICCC

Price:

$10.75

Market Cap:

$97.25M

ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which sp...[Read more]

Industry

Biotechnology

IPO Date

1987-05-05

Stock Exchange

NASDAQ

Ticker

ICCC

The Current Ratio as of August 2026 (TTM) for ImmuCell Corporation (ICCC) is 4.82

According to ImmuCell Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.82. This represents a change of 12.48% compared to the average of 4.29 of the last 4 quarters.

ImmuCell Corporation (ICCC) Historical Current Ratio (quarterly & annually)

How has ICCC Current Ratio performed in the past?

The mean historical Current Ratio of ImmuCell Corporation over the last ten years is 4.53. The current 4.82 Current Ratio has changed 10.55% with respect to the historical average. Over the past ten years (40 quarters), ICCC's Current Ratio was at its highest in in the September 2016 quarter at 12.09. The Current Ratio was at its lowest in in the September 2017 quarter at 1.75.

Quarterly (TTM)
Annual

Average

4.53

Median

4.41

Minimum

2.50

Maximum

6.97

ImmuCell Corporation (ICCC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ImmuCell Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 111.14%

Maximum Annual Current Ratio = 6.97

Minimum Annual Increase = -47.81%

Minimum Annual Current Ratio = 2.50

Quarterly (TTM)
Annual
YearCurrent RatioChange
20254.2624.93%
20243.4124.77%
20232.73-40.02%
20224.56-29.01%
20216.4216.72%
20205.504.03%
20195.29111.14%
20182.50-31.18%
20173.64-47.81%
20166.97-27.63%

ImmuCell Corporation (ICCC) Average Current Ratio

How has ICCC Current Ratio performed in the past?

The current Current Ratio of ImmuCell Corporation (ICCC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.47

5-year avg

4.27

10-year avg

4.53

ImmuCell Corporation (ICCC) Current Ratio vs. Peers

How is ICCC’s Current Ratio compared to its peers?

ImmuCell Corporation’s Current Ratio is less than Equillium, Inc. (18.62), greater than Cue Biopharma, Inc. (3.57), greater than Outlook Therapeutics, Inc. (0.54), greater than Coeptis Therapeutics Holdings, Inc. (3.25), greater than OS Therapies Incorporated (0.05), greater than NRx Pharmaceuticals, Inc. (0.29), greater than Fortress Biotech, Inc. (2.86), less than Century Therapeutics, Inc. (10.25), greater than Senti Biosciences, Inc. (1.04), less than Genenta Science S.p.A. (14.16),

Build a custom stock screener for ImmuCell Corporation (ICCC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuCell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuCell Corporation (ICCC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuCell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is ImmuCell Corporation's Current Ratio?

How is the Current Ratio calculated for ImmuCell Corporation (ICCC)?

What is the highest Current Ratio for ImmuCell Corporation (ICCC)?

What is the 3-year average Current Ratio for ImmuCell Corporation (ICCC)?

What is the 5-year average Current Ratio for ImmuCell Corporation (ICCC)?

How does the current Current Ratio for ImmuCell Corporation (ICCC) compare to its historical average?